Market Indices


Latest News

Neil Young from Needham issued a price target of $20.00 for...

August 12, 2026   QUIK -9.63%

Ryan Deschner from Raymond James issued a price target of $18.00...

August 12, 2026   ACHV -3.19%

Daniel Arias from Stifel Nicolaus issued a price target of $12.00...

August 12, 2026   MASS -1.32%

Needham analyst issues BUY recommendation for QUIK on August 12,...

August 12, 2026   QUIK -9.63%

from Wedbush issued a price target of $27.00 for

August 12, 2026   VOR -5.86%


Price Targets

Neil Young from Needham issued a price target of $20.00 for QUIK on 2026-08-12 13:02:04.The adjusted price target was set to $20.00.At the time of the announcement, QUIK...

August 12, 2026   QUIK -9.63%

Ryan Deschner from Raymond James issued a price target of $18.00 for ACHV on 2026-08-12 12:37:25.The adjusted price target was set to $18.00.At the time of the announcement,

August 12, 2026   ACHV -3.19%

Daniel Arias from Stifel Nicolaus issued a price target of $12.00 for MASS on 2026-08-12 12:22:00.The adjusted price target was set to $12.00.At the time of the announcement,

August 12, 2026   MASS -1.32%

from Wedbush issued a price target of $27.00 for VOR on 2026-08-12 11:58:25.The adjusted price target was set to $27.00.At the time of the announcement, VOR was...

August 12, 2026   VOR -5.86%

from Wedbush issued a price target of $16.00 for FENC on 2026-08-12 11:57:12.The adjusted price target was set to $16.00.At the time of the announcement, FENC was...

August 12, 2026   FENC -5.36%



Market Movers

Top Gainers (%)
XOSWW
Xos, Inc.
0.00
53.85%
IZM
ICZOOM Group Inc.
0.32
21.62%
PESI
Perma-Fix Environmental S
20.59
17.97%
IPHA
Innate Pharma S.A.
2.49
16.02%
BTAI
BioXcel Therapeutics, Inc
1.05
12.67%
ARBEW
Arbe Robotics Ltd.
0.03
11.86%
SST
System1, Inc.
1.88
10.36%
HRTX
Heron Therapeutics, Inc.
0.36
10.07%

Annual/Quarterly Reports Summary

In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...

November 6, 2024   AIP 5.37%

In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...

November 6, 2024   EOSEW -2.33%

In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...

November 6, 2024   EOSE -1.42%

In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...

November 5, 2024   STOK 1.43%

In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...

November 5, 2024   BSVN 1.50%